Anavex Life Sciences
AVXL
#8940
Rank
C$0.31 B
Marketcap
C$3.37
Share price
1.71%
Change (1 day)
-72.13%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -C$55.66 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. , an increase over its 2024 earnings that were of -C$72.91 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 -C$56.56 Million-22.43%
2024 -C$72.91 Million14.77%
2023 -C$63.53 Million-17.49%
2022 -C$76.99 Million22.96%
2021 -C$62.61 Million35.36%
2020 -C$46.26 Million12.65%
2019 -C$41.06 Million29.09%
2018 -C$31.81 Million36.33%
2017 -C$23.34 Million17.11%
2016 -C$19.93 Million20.91%
2015 -C$16.48 Million-6.29%
2014 -C$17.59 Million337.28%
2013 -C$4.03 Million
2008 -C$7.44 Million106.01%
2007 -C$3.61 Million8848.98%
2006 -C$0.05 Million-79.99%
2005 -C$0.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
C$0.26 B-576.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
-C$11.63 Million-79.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-C$8.83 Million-84.39%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-C$0.65 Billion 1,035.69%๐Ÿ‡บ๐Ÿ‡ธ USA